Trials / Completed
CompletedNCT01193543
Effect of Calanus Oli on Intra-abdominal Fat, Glucose Tolerance and Lipids in Man
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 117 (actual)
- Sponsor
- University of Tromso · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Preliminary studies in rats and mice indicate that calanus oil reduce accumulation of intra-abdominal fat. Pilot studies in humans have shown no adverse effects. In the present study 120 subjects, males and females, 20-65 years old, BMI 25-30 kg/m2 will be included and given calanus oli 1 g twice daily versus placebo for 1 year. The hypothesis is that calanus oil will reduce intra-abdominal fat, improve glucose tolerance and lipid profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | calanus oil | 1 gram twice daily |
| DIETARY_SUPPLEMENT | olive oil | 1 gram twice daily |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2012-06-01
- Completion
- 2012-08-01
- First posted
- 2010-09-02
- Last updated
- 2012-09-05
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT01193543. Inclusion in this directory is not an endorsement.